This website is created in the English language. Novartis has not certified or validated the accuracy of any translation of this website made applying online translation tools, and such tools are only made available as a courtesy to the user for translating single words. Novartis disclaims any and all liability for the accuracy of the content of the website when translated from the English language, and all users should always refer to the English version of the website for the validated and accurate information.

Find out how the innovative Chimeric Antigen Receptor (CAR) T cell therapy can help turn a potential cure into your reality.

Are you a patient or caregiver?

Looking to learn more about the diagnosis
and treatment options for
Pediatric Acute Lymphoblastic Leukemia (pALL)
Pediatric Acute Lymphoblastic Leukemia (pALL)
Diffuse Large B-cell Lymphoma (DLBCL)
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma <br/>(FL)
Follicular Lymphoma

Disclaimer:This is global website for information on CAR-T Cell Therapy and is intended for Patients and Caregivers outside the US. The information on the site is not country specific and may contain information that is outside the approved indication in the country in which you are located.